GW Pharmaceuticals Plc (GWPH): Price and Financial Metrics
GW Pharmaceuticals Plc (GWPH)
Today's Latest Price: $156.31 USD
Updated Jan 28 11:11am
Add GWPH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 241 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
GWPH Stock Summary
- GWPH's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 921.1 -- higher than 95.72% of US-listed equities with positive expected earnings growth.
- The ratio of debt to operating expenses for Gw Pharmaceuticals Plc is higher than it is for about just 7.93% of US stocks.
- Revenue growth over the past 12 months for Gw Pharmaceuticals Plc comes in at 133.62%, a number that bests 95.7% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Gw Pharmaceuticals Plc, a group of peers worth examining would be AIRG, SWAV, OOMA, PRO, and AEHR.
- GWPH's SEC filings can be seen here. And to visit Gw Pharmaceuticals Plc's official web site, go to www.gwpharm.com.
GWPH Stock Price Chart Interactive Chart >
GWPH Price/Volume Stats
| Current price | $156.31 | 52-week high | $162.87 |
| Prev. close | $158.47 | 52-week low | $67.98 |
| Day low | $156.31 | Volume | 102,753 |
| Day high | $162.00 | Avg. volume | 419,276 |
| 50-day MA | $128.07 | Dividend yield | N/A |
| 200-day MA | $116.50 | Market Cap | 4.85B |
GW Pharmaceuticals Plc (GWPH) Company Bio
GW Pharmaceuticals plc, a biopharmaceutical company, engages in discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. It operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The company was founded in 1998 and is based in Cambridge, the United Kingdom.
Loading social stream, please wait...